⌘K
Loading ticker…
As of 2026-08-21, Exagen Inc. Common Stock (XGN) has a 3-month relative strength percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 67. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.5%, relative volume 0.54×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
XGN is held by 4 ETFs as of Apr 2026. Top owner: DFAS at 0.00% weight, $73K notional. Top 3 carry $93K.
Held by 7 ETFs · $2M across latest filings · largest weight 0.03% (IWC).
Top 4 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFASDimensional U.S. Small Cap ETF | 0.00% | $73K | new |
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $10K | — |
| DFSU | 0.00% | $10K | — |
| DCOR | 0.00% | $5K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XGN Jan avg: -3.89% median: 2.80% win: 50% σ: 25.20% n: 4 2022-04-12 → 2026-07-31 | XGN Feb avg: -5.17% median: -5.92% win: 25% σ: 8.24% n: 4 2022-04-12 → 2026-07-31 | XGN Mar avg: -11.85% median: -10.92% win: 25% σ: 14.47% n: 4 2022-04-12 → 2026-07-31 | XGN Apr avg: 11.49% median: -3.33% win: 40% σ: 35.23% n: 5 2022-04-12 → 2026-07-31 | XGN May avg: 24.90% median: 18.50% win: 80% σ: 33.56% n: 5 2022-04-12 → 2026-07-31 | XGN Jun avg: -0.34% median: -3.65% win: 40% σ: 8.95% n: 5 2022-04-12 → 2026-07-31 | XGN Jul avg: 7.70% median: 7.14% win: 60% σ: 17.55% n: 5 2022-04-12 → 2026-07-31 | XGN Aug avg: 8.48% median: 9.91% win: 75% σ: 37.89% n: 4 2022-04-12 → 2026-07-31 (current) | XGN Sep avg: -7.25% median: -0.14% win: 50% σ: 22.84% n: 4 2022-04-12 → 2026-07-31 | XGN Oct avg: -13.53% median: -15.48% win: 25% σ: 15.44% n: 4 2022-04-12 → 2026-07-31 | XGN Nov avg: 12.22% median: 8.90% win: 75% σ: 39.26% n: 4 2022-04-12 → 2026-07-31 | XGN Dec avg: -5.68% median: -3.92% win: 50% σ: 14.17% n: 4 2022-04-12 → 2026-07-31 |